Laurus Labs Share Price Momentum After Strong June Quarter Results

Key Takeaways
- Laurus Labs share price reached a fresh 52-week high on strong June quarter results.
- Revenue rose 29% YoY to Rs 2,026 crore with EBITDA margin at 31.5% and net profit Rs 368 crore.
- Analysts show 11 Buy, 4 Hold, and 4 Sell ratings with a 12-month target of Rs 1,630.33.
- Volume surged to 2.53x 30-day average and RSI stood at 71.46.
Laurus Labs Share Price momentum surged to a fresh 52-week high of Rs 1,752.70 on Tuesday as the June quarter FY27 results landed, signaling a shift in momentum for this pharma mid-cap. The Laurus Labs share price rose 2.29% intraday, with volume at 2.53x its 30-day average and the RSI reading at 71.46, underscoring robust buying interest among traders.
Laurus Labs Share Price Momentum After Strong June Quarter Results
The June quarter numbers reinforced the growth narrative, with revenue up 29% YoY to Rs 2,026 crore from Rs 1,570 crore a year ago. EBITDA advanced 67% to Rs 638 crore, and EBITDA margin widened to 31.5% from 24.3% year-ago levels. Net profit rose to Rs 368 crore, up from Rs 163 crore, reflecting improved business mix and higher CDMO contribution.
The intraday move occurred as the scrip rose to Rs 1,752.70 on Tuesday at 10:45 a.m., with the day’s volume at 2.53x the 30-day average. The Nifty 50 rose 0.15% on the day as broader markets turned cautious.
Key Financial Snapshot From The June Quarter
Here is a compact table of the June quarter metrics to illustrate the scale and the trend:
| Metric | Value |
|---|---|
| June Quarter Revenue | Rs 2,026 crore |
| YoY Revenue Growth | 29% |
| EBITDA | Rs 638 crore |
| EBITDA Margin | 31.5% |
| Net Profit | Rs 368 crore |
| Net Profit (YoY) | From Rs 163 crore to Rs 368 crore |
| 52-Week High | Rs 1,752 |
| Intraday High | Rs 1,752.70 |
| Volume vs 30-day Avg | 2.53x |
| RSI | 71.46 |
| Analyst Coverage | 19 analysts; 11 Buy, 4 Hold, 4 Sell |
| 12-Month Target | Rs 1,630.33 |
| Implied Downside To Target | 6.2% |
Analysts tracking Laurus Labs show a mix of views, with 11 Buy, 4 Hold and 4 Sell ratings among 19 coverage notes. The average 12-month target of Rs 1,630.33 implies a downside of about 6.2% from the current price, suggesting the market is pricing in some valuation headwinds even as earnings momentum remains solid.
In terms of strategic drivers, the company has benefited from an improved business mix and a higher contribution from its Contract Development and Manufacturing Organisation business, along with better capacity utilisation. If this trend persists, Laurus Labs stock could sustain its upmove for a period, especially as CDMO volumes rise and the company continues to leverage capacity.
To aid your decision-making, consider Swastika's Sarthi AI stock assistant.
What Retail Investors Should Watch
Retail investors should monitor the CDMO-driven revenue stream and capacity utilisation trajectory, as these are key earnings drivers. While price action has remained resilient, the current consensus target suggests a near-term downside; investors should weigh this against the potential for margin expansion if demand remains robust. The balance of growth drivers and valuation will shape the stock's path in the near term.
To refine your approach, consider the Swastika Sarthi AI stock assistant for tailored insights and scenario planning.
Related Reads
- Laurus Labs Share Price Rally: Q1FY27 Profit Jump And Growth Drivers
- Infosys Stock Price Signals And Market Moves: Nifty Ends Lower As IT Leads
Frequently Asked Questions
What was Laurus Labs' revenue in the June quarter?
The June quarter revenue was Rs 2,026 crore, up 29% year on year from Rs 1,570 crore.
What was Laurus Labs EBITDA margin in the June quarter?
EBITDA margin expanded to 31.5% in the June quarter FY27, up from 24.3% in the year-ago quarter.
What was Laurus Labs net profit in the June quarter?
Net profit was Rs 368 crore, more than doubling from Rs 163 crore in the year-ago quarter.
Did Laurus Labs share price hit a 52-week high recently?
Yes, the share price rose to a fresh 52-week high of Rs 1,752, with intraday high at Rs 1,752.70.
What do analysts say about Laurus Labs stock?
Analysts tracking the company include 11 Buy, 4 Hold, and 4 Sell ratings, with a 12-month target of Rs 1,630.33.
Conclusion
In the near term, Laurus Labs demonstrates a growth story supported by 29% revenue growth to Rs 2,026 crore and a margin expansion to 31.5% in the June quarter. The 52-week high and intraday momentum reflect strong investor interest, but the implied downside from the consensus target indicates valuation constraints may cap gains. Retail investors should apply a disciplined approach, focusing on earnings acceleration, CDMO contributions, and capacity utilisation as they assess entry and exit points.
Open your trading and demat account here
Reference :
1 : Ndtvprofit


START YOUR INVESTMENT JOURNEY
Get personalized advice from our experts
- Dedicated RM Support
- Smooth and Fast Trading App



















.avif)
.avif)

.avif)
